Robert J. Ignoffo, PharmD, FASHP, FCSHP

Professor of Pharmacy
College of Pharmacy
Touro University–California, Mare Island
Vallejo, CA
Clinical Professor Emeritus
University of California
San Francisco, CA

Authored Items

Novel Systemic Therapies for Advanced Non–Small-Cell Lung Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP, Tristan Lindfelt, PharmD, BCPS, BCACP, BCOP, Eric Lozano

JHOP - March 2017 Vol 7, No 1 in Review Article

Concise Review of Obinutuzumab in the Treatment of Patients with Chronic Lymphocytic Leukemia

Peter Tang, PharmD Candidate, Tristan Lindfelt, PharmD, BCPS, BCACP, BCOP, Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - June 2014 VOL 4, NO 2 in Drug Updates

Rituximab Maintenance Prolongs Progression-Free Survival in Patients with Relapsed Follicular Lymphoma Undergoing High-Dose Chemotherapy and Autologous Transplantation

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - June 2013 VOL 3, NO 2 in From the Literature

Crizotinib Superior to Standard Chemotherapy in Patients with ALK-Positive Lung Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - June 2013 VOL 3, NO 2 in From the Literature

Neoadjuvant Lapatinib and Trastuzumab with Hormonal Therapy and No Chemotherapy Beneficial in Patients with HER2 Breast Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - June 2013 VOL 3, NO 2 in From the Literature

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - March 2013 VOL 3, NO 1

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - December 2012 VOL 2, NO 4 in From the Literature

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - June 2012, Vol 2, No 2 in From the Literature

Bevacizumab Delays Progression in Women with Advanced Ovarian Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - March 2012, VOL 2 NO 1 in From the Literature, From the Literature

Combination Therapy with Pertuzumab Offers New Option in Metastatic Breast Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - March 2012, VOL 2 NO 1 in From the Literature, From the Literature

Chemotherapy-Induced Changes in Brain Structure Correlate with Cognitive Dysfunction

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - March 2012, VOL 2 NO 1 in From the Literature, From the Literature

BRAF Inhibitor Therapy Linked to Squamous-Cell Carcinoma in Patients with RAS Mutations

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - March 2012, VOL 2 NO 1 in From the Literature, From the Literature

Adding Bevacizumab to Neoadjuvant Chemotherapy Improves Complete Response Rates in Patients with Breast Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - March 2012, VOL 2 NO 1 in From the Literature, From the Literature

Concise Reviews from the Literature Relevant to Hematology Oncology Pharmacy

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - September 2011, Vol 1, No 3 in From the Literature

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - June 2011, Vol 1, No 2 in From the Literature

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy

Robert J. Ignoffo, PharmD, FASHP, FCSHP

JHOP - March 2011, Vol 1, No 1

Last modified: June 29, 2018